Evidence map›Paper›PMID 29468062›Full record

ArticleMolecular and clinical oncology2018

Characterization of oncogene suppressor marker expression in patients with submucosal gastric carcinoma.

Roberson A Moron, Carlos Eduardo Jacob, Claudio José Caldas Bresciani, Kleber Simões, Venâncio Avancini Ferreira Alves, Kyoshi Irya, Joaquim Gama-Rodrigues, Ivan Cecconello, Adhemar Longatto-Filho, Bruno Zilberstein

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecular and clinical oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 72% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Roberson A MoronDepartment of Gastroenterology, University of São Paulo School of Medicine, São Paulo, SP 14784-400, Brazil.
Carlos Eduardo JacobDepartment of Gastroenterology, University of São Paulo School of Medicine, São Paulo, SP 14784-400, Brazil.
Claudio José Caldas BrescianiDepartment of Gastroenterology, University of São Paulo School of Medicine, São Paulo, SP 14784-400, Brazil.
Kleber SimõesDepartment of Pathology, University of São Paulo School of Medicine, São Paulo, SP 14784-400, Brazil.
Venâncio Avancini Ferreira AlvesDepartment of Pathology, University of São Paulo School of Medicine, São Paulo, SP 14784-400, Brazil.
Kyoshi IryaDepartment of Pathology, University of São Paulo School of Medicine, São Paulo, SP 14784-400, Brazil.
Joaquim Gama-RodriguesDepartment of Gastroenterology, University of São Paulo School of Medicine, São Paulo, SP 14784-400, Brazil.
Ivan CecconelloDepartment of Gastroenterology, University of São Paulo School of Medicine, São Paulo, SP 14784-400, Brazil.
Adhemar Longatto-FilhoDepartment of Pathology, University of São Paulo School of Medicine, São Paulo, SP 14784-400, Brazil.
Bruno ZilbersteinDepartment of Gastroenterology, University of São Paulo School of Medicine, São Paulo, SP 14784-400, Brazil.
Universidade de São Paulo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of the present study was to determine the clinical significance of p53 and p21

Indexed as

gastric cancerp16ink4ap21rasp21waf1/cip1p27kip1p53

Identifiers

PMID29468062
PMCPMC5791426
OpenAlexW2776839948

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.